Zacks Investment Management Arvinas, Inc. Transaction History
Zacks Investment Management
- $8.87 Billion
- Q2 2024
A detailed history of Zacks Investment Management transactions in Arvinas, Inc. stock. As of the latest transaction made, Zacks Investment Management holds 81,798 shares of ARVN stock, worth $2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
81,798
Previous 75,821
7.88%
Holding current value
$2 Million
Previous $3.13 Million
30.43%
% of portfolio
0.02%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
68.6MCall Options Held
166KPut Options Held
31.3K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$165 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$163 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$153 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$97.6 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$73.1 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.3B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...